細菌による癌治療のメカニズムを解明(Researchers Reveal Key Mechanism Behind Bacterial Cancer Therapy)

2025-03-04 中国科学院(CAS)

<関連情報>

• https://english.cas.cn/newsroom/research_news/life/202502/t20250226_902603.shtml
• https://www.cell.com/cell/abstract/S0092-8674(25)00158-8

IL-10Rのヒステリシスを利用した細菌免疫療法による貪食回避と腫瘍免疫の活性化 Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization

Zhiguang Chang∙ Xuan Guo∙ Xuefei Li∙ … ∙ Jian-Dong Huang∙ Yichuan Xiao∙ Chenli Liu (刘陈立)
Cell  Published:March 3, 2025
DOI:https://doi.org/10.1016/j.cell.2025.02.002

Graphical abstract

Highlights

•IL-10 induces IL-10R expression, forming a positive feedback loop and hysteresis
•Hysteresis drives tumor-infiltrating immune cells into an IL-10R^hi state
•Bacteria induce TAMs to secrete IL-10, evading TANs while activating CD8⁺ TRM cells
•Tumor-infiltrating IL-10R^hi immune cells present across most human solid tumor types

Summary

Bacterial immunotherapy holds promising cancer-fighting potential. However, unlocking its power requires a mechanistic understanding of how bacteria both evade antimicrobial immune defenses and stimulate anti-tumor immune responses within the tumor microenvironment (TME). Here, by harnessing an engineered Salmonella enterica strain with this dual proficiency, we unveil an underlying singular mechanism. Specifically, the hysteretic nonlinearity of interleukin-10 receptor (IL-10R) expression drives tumor-infiltrated immune cells into a tumor-specific IL-10R^hi state. Bacteria leverage this to enhance tumor-associated macrophages producing IL-10, evade phagocytosis by tumor-associated neutrophils, and coincidently expand and stimulate the preexisting exhausted tumor-resident CD8⁺ T cells. This effective combination eliminates tumors, prevents recurrence, and inhibits metastasis across multiple tumor types. Analysis of human samples suggests that the IL-10R^hi state might be a ubiquitous trait across human tumor types. Our study unveils the unsolved mechanism behind bacterial immunotherapy’s dual challenge in solid tumors and provides a framework for intratumoral immunomodulation.